Free Trial

Enzon Pharmaceuticals (ENZN) Short Interest Ratio & Short Volume

Enzon Pharmaceuticals logo
$0.09 +0.01 (+6.00%)
As of 04/24/2025 03:19 PM Eastern

Enzon Pharmaceuticals Short Interest Data

Enzon Pharmaceuticals (ENZN) has a short interest of 20,300 shares, representing 0.03% of the float (the number of shares available for trading by the public). This marks a 217.19% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 67,840 shares to cover all short positions.

Current Short Interest
20,300 shares
Previous Short Interest
6,400 shares
Change Vs. Previous Month
+217.19%
Dollar Volume Sold Short
$2,088.87
Short Interest Ratio
0.4 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
74,215,000 shares
Short Percent of Float
0.03%
Today's Trading Volume
20,250 shares
Average Trading Volume
67,840 shares
Today's Volume Vs. Average
30%
Short Selling Enzon Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ENZN Short Interest Over Time

ENZN Days to Cover Over Time

ENZN Percentage of Float Shorted Over Time

Enzon Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202520,300 shares $2,088.87 +217.2%0.0%0.4 $0.10
3/15/20256,400 shares $646.40 -12.3%0.0%0.1 $0.10
2/28/20257,300 shares $803.00 +55.3%0.0%0 $0.11
2/15/20254,700 shares $632.62 -91.5%0.0%0.1 $0.13
1/31/202555,100 shares $8,242.96 +2,523.8%N/A0.3 $0.15
1/15/20252,100 shares $301.56 -74.1%N/A0 $0.14
12/31/20248,100 shares $1,264.41 +406.3%N/A0 $0.16
12/15/20241,600 shares $182.00 No ChangeN/A0 $0.11
11/30/20241,600 shares $128.00 No ChangeN/A0 $0.08
11/15/20241,600 shares $131.20 -40.7%N/A0.1 $0.08
10/31/20242,700 shares $243.00 +68.8%N/A0 $0.09
10/15/20241,600 shares $187.52 No ChangeN/A0.1 $0.12
9/30/20241,600 shares $224.00 -33.3%N/A0.1 $0.14
9/15/20242,400 shares $302.54 +50.0%N/A0 $0.13
8/31/20241,600 shares $232.96 No ChangeN/A0.1 $0.15
8/15/20241,600 shares $256.32 -64.4%N/A0 $0.16
7/31/20244,500 shares $675.00 -61.2%N/A0.3 $0.15
7/15/202411,600 shares $1,787.56 -37.0%N/A0.8 $0.15
6/30/202418,400 shares $3,312.00 -3.7%N/A0.7 $0.18
6/15/202419,100 shares $2,677.82 -28.5%N/A0.1 $0.14
5/31/202426,700 shares $3,471.00 +1,568.8%N/A0.2 $0.13
5/15/20241,600 shares $144.00 No ChangeN/A0 $0.09
4/30/20241,600 shares $133.52 -87.6%N/A1.5 $0.08
4/15/202412,900 shares $964.92 +239.5%N/A0.6 $0.07
3/31/20243,800 shares $359.10 +137.5%N/A0.1 $0.09
3/15/20241,600 shares $132.48 -73.3%N/A0 $0.08
2/29/20246,000 shares $393.00 +275.0%N/A0.3 $0.07
2/15/20241,600 shares $144.00 -20.0%N/A0.1 $0.09
1/15/20241,600 shares $142.08 No ChangeN/A0.1 $0.09
12/31/20231,600 shares $149.68 -42.9%N/A0 $0.09
12/15/20232,800 shares $288.40 -58.2%N/A0.1 $0.10
11/30/20236,700 shares $703.50 +318.8%N/A0.1 $0.11
11/15/20231,600 shares $224.00 No ChangeN/A0.3 $0.14
10/31/20231,600 shares $240.00 No ChangeN/A0.1 $0.15
10/15/20231,600 shares $221.12 No ChangeN/A0.1 $0.14
9/30/20231,600 shares $234.68 -76.8%N/A0.2 $0.15
9/15/20236,900 shares $938.40 -42.0%N/A0.3 $0.14
8/31/202311,900 shares $1,844.50 +643.8%N/A0.7 $0.16
8/15/20231,600 shares $240.00 -27.3%N/A0.1 $0.15
7/31/20232,200 shares $440.00 No ChangeN/A0.3 $0.20
[Action Required] Claim Your FREE IRS Loophole Guide (Ad)

This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.

So claim your FREE copy of this 2025 Gold Guide to learn more.
7/15/20232,200 shares $440.00 -57.7%N/A0.2 $0.20
6/30/20235,200 shares $1,040.00 +136.4%N/A0.1 $0.20
6/15/20232,200 shares $310.20 -33.3%N/A0.1 $0.14
5/31/20233,300 shares $445.50 +106.3%N/A0.1 $0.14
5/15/20231,600 shares $251.20 No ChangeN/A0 $0.16
4/30/20231,600 shares $328.00 -33.3%N/A0.2 $0.21
4/15/20232,400 shares $494.40 -7.7%N/A0.1 $0.21
3/31/20232,600 shares $676.00 -75.5%N/A0.1 $0.26
3/15/202310,600 shares $2,647.88 +523.5%N/A0.5 $0.25
2/28/20231,700 shares $433.50 -81.1%N/A0 $0.26
2/15/20239,000 shares $2,475.00 +350.0%N/A0.7 $0.28
1/31/20232,000 shares $530.00 -85.2%N/A0.2 $0.27
1/15/202313,500 shares $3,510.00 -27.0%N/A0.2 $0.26
12/30/202218,500 shares $4,563.03 No ChangeN/A0.4 $0.25
12/15/202218,500 shares $4,838.86 +1,056.3%N/A0.5 $0.26
11/30/20221,600 shares $439.68 -92.1%N/A0.1 $0.27
11/15/202220,200 shares $5,454.00 +910.0%N/A0.3 $0.27
10/31/20222,000 shares $580.00 -73.3%N/A0 $0.29
10/15/20227,500 shares $2,100.00 -7.4%N/A0.5 $0.28
9/30/20228,100 shares $2,292.30 +268.2%N/A0.1 $0.28
9/15/20222,200 shares $679.36 -66.2%N/A0.1 $0.31
8/31/20226,500 shares $1,768.00 +140.7%N/A0 $0.27
8/15/20222,700 shares $1,077.30 -54.2%N/A0 $0.40
7/31/20225,900 shares $1,976.50 +247.1%N/A0.2 $0.34
7/15/20221,700 shares $501.50 -95.2%N/A0 $0.30
6/30/202235,200 shares $10,736.00 +2,100.0%N/A0.3 $0.31
6/15/20221,600 shares $448.00 -5.9%N/A0 $0.28
5/31/20221,700 shares $518.50 -56.4%N/A0.1 $0.31
5/15/20223,900 shares $1,150.50 -81.7%N/A0.1 $0.30
4/30/202221,300 shares $6,713.76 +191.8%N/A0.2 $0.32
4/15/20227,300 shares $2,568.14 +265.0%N/A0.1 $0.35
3/31/20222,000 shares $604.80 -35.5%N/A0.1 $0.30
3/15/20223,100 shares $931.55 +24.0%N/A0.1 $0.30
2/28/20222,500 shares $800.00 -30.6%N/A0.1 $0.32
2/15/20223,600 shares $1,311.12 +125.0%N/A0 $0.36
1/31/20221,600 shares $656.00 -81.4%N/A0 $0.41
1/15/20228,600 shares $3,053.00 +437.5%N/A0.2 $0.36
12/31/20211,600 shares $548.00 No ChangeN/A0 $0.34
12/15/20211,600 shares $528.00 -76.5%N/A0 $0.33
11/30/20216,800 shares $2,512.60 -53.7%N/A0 $0.37
11/15/202114,700 shares $5,143.53 +818.8%N/A0.1 $0.35
10/29/20211,600 shares $511.52 -40.7%N/A0 $0.32
10/15/20212,700 shares $915.30 -30.8%N/A0.1 $0.34
9/30/20213,900 shares $1,471.86 -48.7%N/A0 $0.38
9/15/20217,600 shares $2,750.44 -12.6%N/A0.1 $0.36
8/31/20218,700 shares $2,872.74 +8.8%N/A0.1 $0.33
8/13/20218,000 shares $3,280.00 -16.7%N/A0 $0.41
7/30/20219,600 shares $5,181.12 +15.7%N/A0.1 $0.54
7/15/20218,300 shares $5,436.50 +196.4%N/A0.1 $0.66
6/30/20212,800 shares $1,848.00 -60.0%N/A0 $0.66
[Action Required] Claim Your FREE IRS Loophole Guide (Ad)

This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.

So claim your FREE copy of this 2025 Gold Guide to learn more.
6/15/20217,000 shares $5,173.00 -7.9%N/A0.1 $0.74
5/28/20217,600 shares $4,405.72 +31.0%N/A0.1 $0.58
5/14/20215,800 shares $3,221.90 -34.8%N/A0.1 $0.56
4/30/20218,900 shares $5,340.00 +178.1%N/A0.1 $0.60
4/15/20213,200 shares $2,300.80 -76.8%N/A0 $0.72
3/31/202113,800 shares $10,555.62 +762.5%N/A0.1 $0.76
3/15/20211,600 shares $1,008.00 -76.5%N/A0 $0.63
2/26/20216,800 shares $4,178.87 +161.5%N/A0 $0.61
2/12/20212,600 shares $1,567.28 -94.1%N/A0 $0.60
1/29/202144,400 shares $19,536.00 +21.6%N/A0.1 $0.44
1/15/202143,700 shares $13,765.50 +241.4%N/A0.1 $0.32
12/31/202024,500 shares $6,588.05 -43.9%N/A0.1 $0.27
12/15/202043,700 shares $10,925.00 +241.4%N/A0.1 $0.25
11/30/202012,800 shares $2,329.60 -36.6%N/A0.1 $0.18
11/15/202020,200 shares $3,050.20 +5.8%N/A0.2 $0.15
10/30/202019,100 shares $2,779.05 +135.8%N/A0.2 $0.15
10/15/20208,100 shares $1,297.62 +88.4%N/A0 $0.16
9/30/20204,300 shares $796.36 -62.0%N/A0.1 $0.19
9/15/202011,300 shares $1,989.93 -29.8%N/A0.1 $0.18
8/31/202016,100 shares $3,052.56 -53.9%N/A0.1 $0.19
8/14/202034,900 shares $7,503.50 +122.3%N/A0.1 $0.22
7/31/202015,700 shares $3,140.00 -38.2%N/A0.3 $0.20
7/15/202025,400 shares $4,140.20 +103.2%N/A0.8 $0.16
6/30/202012,500 shares $2,180.00 -30.2%N/A0.8 $0.17
6/15/202017,900 shares $3,141.45 -67.7%N/A0.5 $0.18
5/29/202055,400 shares $9,911.06 +32.2%N/A3 $0.18
5/15/202041,900 shares $7,521.05 -31.7%N/A0.9 $0.18
4/30/202061,300 shares $11,003.35 +656.8%N/A0.8 $0.18

ENZN Short Interest - Frequently Asked Questions

What is Enzon Pharmaceuticals' current short interest?

Short interest is the volume of Enzon Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 20,300 shares of ENZN short. 0.03% of Enzon Pharmaceuticals' shares are currently sold short. Learn More on Enzon Pharmaceuticals' current short interest.

What is a good short interest percentage for Enzon Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.03% of Enzon Pharmaceuticals' floating shares are currently sold short.

Is Enzon Pharmaceuticals' short interest increasing or decreasing?

Enzon Pharmaceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 20,300 shares, an increase of 217.2% from the previous total of 6,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Enzon Pharmaceuticals' short interest compare to its competitors?

0.03% of Enzon Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Enzon Pharmaceuticals: SAB Biotherapeutics, Inc. (1.24%), Bolt Biotherapeutics, Inc. (0.98%), Curis, Inc. (1.74%), Molecular Templates, Inc. (5.48%), Amgen Inc. (2.63%), Gilead Sciences, Inc. (1.73%), Vertex Pharmaceuticals Incorporated (1.74%), Regeneron Pharmaceuticals, Inc. (2.76%), Alnylam Pharmaceuticals, Inc. (2.34%), Biogen Inc. (2.29%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Enzon Pharmaceuticals stock?

Short selling ENZN is an investing strategy that aims to generate trading profit from Enzon Pharmaceuticals as its price is falling. ENZN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Enzon Pharmaceuticals?

A short squeeze for Enzon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENZN, which in turn drives the price of the stock up even further.

How often is Enzon Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENZN, twice per month. The most recent reporting period available is March, 31 2025.




This page (OTCMKTS:ENZN) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners